Literature DB >> 11408512

The case for a new national program for the development of cancer therapeutics.

P S Schein1.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11408512     DOI: 10.1200/JCO.2001.19.12.3142

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Balancing safety, effectiveness, and public desire: the FDA and cancer.

Authors:  Rena Conti
Journal:  Issue Brief (Commonw Fund)       Date:  2003-04

2.  Treating refractory leukemias in childhood, role of clofarabine.

Authors:  Theresa M Harned; Paul S Gaynon
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.